Neurocrine Biosciences Inc (NBIX): Kapitalflussrechnung
Kennzahl in 1000 USD | TTM 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 | 2005-12-31 | 2004-12-31 | 2003-12-31 | 2002-12-31 | 2001-12-31 | 2000-12-31 | 1999-12-31 | 1998-12-31 | 1997-12-31 | 1996-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Umsatz | 3.373.900 | 2.860.500 | 2.355.300 | 1.887.100 | 1.488.700 | 1.133.500 | 1.045.900 | 788.100 | 451.240 | 161.626 | 15.000 | 19.769 | 2.919 | 53.140 | 77.413 | 33.501 | 2.953 | 3.975 | 1.224 | 39.234 | 123.889 | 85.176 | 139.078 | 18.045 | 41.242 | 14.588 | 16.800 | 16.000 | 26.100 | 19.200 |
Cashflow aus operativer Geschäftstätigkeit | 898.100 | 782.700 | 595.400 | 389.900 | 339.400 | 256.500 | 228.500 | 147.000 | 101.400 | -94.331 | -106.181 | -37.997 | -29.607 | -35.294 | -698 | 49.943 | -53.095 | -74.165 | -59.334 | -99.334 | -30.794 | -99.988 | 37.128 | -79.365 | -21.856 | -18.645 | -10.300 | -10.700 | 11.000 | 6.700 |
▸ Operative Cashflow Marge | 26,62% | 27,36% | 25,28% | 20,66% | 22,8% | 22,63% | 21,85% | 18,65% | 22,47% | -58,36% | -707,87% | -192,2% | -1.014,29% | -66,42% | -0,9% | 149,08% | -1.798% | -1.865,79% | -4.847,55% | -253,18% | -24,86% | -117,39% | 26,7% | -439,82% | -52,99% | -127,81% | -61,31% | -66,87% | 42,15% | 34,9% |
Investitionsausgaben (CapEx) | 32.500 | 34.000 | 38.200 | 28.300 | 16.500 | 23.400 | 10.900 | 14.700 | 24.800 | 6.940 | 4.108 | 1.934 | 545 | 971 | 750 | 315 | 35 | 1.322 | 624 | 3.110 | 7.235 | 53.147 | 50.439 | 5.300 | 3.805 | 2.440 | 2.100 | 3.700 | 6.400 | 1.600 |
Cashflow aus Investitionstätigkeit | -891.200 | -264.399,999 | -126.800 | -467.100 | -177.100 | -130.200 | 4.100 | -211.100 | -242.900 | -251.253 | 112.955 | -195.814 | 5.340 | -34.761 | -3.532 | -54.704 | 12.057 | 44.420 | 20.836 | 120.281 | 9.382 | 18.469 | -186.646 | -46.021 | -16.637 | -75.674 | -21.200 | 4.700 | -7.200 | - |
Cashflow aus Finanzierungstätigkeit | 60.200 | -38.300 | -486.700 | 65.300 | -234.300 | 27.400 | -157.800 | 32.400 | 29.500 | 516.646 | 2.390 | 276.992 | 5.302 | 83.702 | 286 | 21.483 | 9.900 | -1.452 | 57.181 | 10.086 | 10.333 | 36.692 | 211.059 | 5.811 | 181.303 | 94.132 | 41.000 | 1.900 | 700 | 46.800 |
Freier Cashflow | 865.600 | 748.700 | 557.200 | 361.600 | 322.900 | 233.100 | 217.600 | 132.300 | 76.600 | -101.271 | -110.289 | -39.931 | -30.152 | -36.265 | -1.448 | 49.628 | -53.130 | -75.487 | -59.958 | -102.444 | -38.029 | -153.135 | -13.311 | -84.665 | -25.661 | -21.085 | -12.400 | -14.400 | 4.600 | 5.100 |
▸ Freie Cashflow Marge | 25,66% | 26,17% | 23,66% | 19,16% | 21,69% | 20,56% | 20,81% | 16,79% | 16,98% | -62,66% | -735,26% | -201,99% | -1.032,96% | -68,24% | -1,87% | 148,14% | -1.799,19% | -1.899,04% | -4.898,53% | -261,11% | -30,7% | -179,79% | -9,57% | -469,19% | -62,22% | -144,54% | -73,81% | -90% | 17,62% | 26,56% |
Ausgeschüttete Dividenden | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Neuausgabe und Rückkäufe von Stammaktien | -66.000 | -167.700 | -300.000 | - | 44.700 | 27.500 | 29.100 | 27.313 | 29.530 | 13.865 | 2.390 | 276.992 | 5.302 | 83.702 | 286 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Kennzahlen dieser Seite im Lexikon
Weitere Informationen findest du im Takani-Lexikon.